NFKB1 and AL amyloidosis: Based on the fact that curcumin overcomes chemoresistance and sensitizes multiple myeloma cells to thalidomide and bortezomib by downregulating NF-κB and NF-κB-regulated genes [127], recent studies focused on the design and biological characterization of hybrid compounds associating curcumin with these two molecules [128].